Quantcast

Industry news that matters to you.  Learn more

FLUIDDA Presents Novel Imaging Technology for Respiratory Diseases to FDA

Functional Respiratory Imaging (FRI) is FLUIDDA’s proprietary imaging technology with the unique capability of producing highly clinical relevant patient specific biomarkers. These biomarkers present 3D visualization of the patient’s airway and lung geometry, airway resistance and aerosol deposition patterns.